Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · Real-Time Price · USD

1.500

+0.120 (8.70%)

At close: Oct 15, 2026, 4:00 PM EDT

1.480

-0.020 (-1.33%)

After-hours: Oct 15, 2026, 7:30 PM EDT

Century Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	272	87	86	199	303	867
Market Cap Growth	471.75%	1.14%	-56.77%	-34.34%	-65.09%	-
Enterprise Value	191	-1	-58	77	-6	597
Last Close Price	1.50	0.99	1.01	3.32	5.13	15.86

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	-	0.80	13.03	88.88	58.19	-
PB Ratio	1.17	0.55	0.53	1.08	1.00	2.19
P/TBV Ratio	1.37	0.70	0.68	1.08	1.00	2.19
P/OCF Ratio	-	-	-	-	21.53	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	-	-	34.33	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.17	0.27	0.33	0.26	0.16	0.06
Debt / EBITDA Ratio	-	5.79	-	-	-	-
Net Debt / Equity Ratio	-0.35	-0.46	-0.84	-0.67	-0.88	-0.50
Net Debt / EBITDA Ratio	0.85	37.93	1.11	1.11	2.31	2.17
Net Debt / FCF Ratio	0.92	0.70	1.23	1.22	16.08	1.48
Asset Turnover	-	0.38	0.02	0.01	0.01	-
Quick Ratio	8.04	5.82	1.47	9.81	10.61	14.25
Current Ratio	8.28	5.97	1.50	9.92	10.72	14.57
Return on Equity (ROE)	-49.65%	-5.98%	-73.14%	-56.07%	-37.46%	-40.81%
Return on Assets (ROA)	-23.51%	-3.26%	-23.67%	-18.47%	-16.75%	-21.80%
Return on Capital Employed (ROCE)	-39.50%	-7.40%	-60.50%	-36.50%	-27.10%	-22.50%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-40.42%	-11.03%	-147.38%	-68.80%	-43.28%	-11.06%
FCF Yield	-32.43%	-120.57%	-128.42%	-51.39%	-5.47%	-15.46%
Buyback Yield / Dilution	-67.40%	-10.05%	-32.60%	-2.70%	-78.30%	-332.95%

SEC Filings: 10-K · 10-Q